Nephrotic Syndrome and a Retroperitoneal Mass: A Case Report of a Patient with Recurrent Invasive Thymoma

Overview

Journal Intern Med

Specialty General Medicine

Date 2017 Oct 13

PMID 29021446

Citations 2

Authors

Hiroaki Myoga

Tetsu Akimoto

Naoko Mato

Takakiyo Nakaya

Takuya Murakami

Hiromichi Yoshizawa

Saki Nakagawa

Atsushi Miki

Takahiro Masuda

Takahisa Kobayashi

Yuko Ono

Osamu Saito

Yoshihiko Ueda

Shigeaki Muto

Daisuke Nagata

Affiliations

Soon will be listed here.

Abstract

A 68-year-old man was admitted to our hospital to undergo an examination for nephrotic syndrome while concurrently complicated with recurrent thymoma in the parietal pleura and retroperitoneum. He had been diagnosed with invasive thymoma and had undergone thymo-thymectomy seven years previously. Based on the renal biopsy findings, his nephrotic syndrome was ascribed to minimal change disease. He was treated with corticosteroid monotherapy, which resulted in complete remission six months later, despite the fact that the recurrent thymoma remained. The role of thymoma in the pathogenesis of paraneoplastic glomerulopathy and the therapeutic concerns that emerged in this case are also discussed.

Citing Articles

Application of a combined radiomics nomogram based on CE-CT in the preoperative prediction of thymomas risk categorization.

Dong W, Xiong S, Lei P, Wang X, Liu H, Liu Y Front Oncol. 2022; 12:944005.

PMID: 36081562 PMC: 9446086. DOI: 10.3389/fonc.2022.944005.

Autoimmune disorders and paraneoplastic syndromes in thymoma.

Blum T, Misch D, Kollmeier J, Thiel S, Bauer T J Thorac Dis. 2021; 12(12):7571-7590.

PMID: 33447448 PMC: 7797875. DOI: 10.21037/jtd-2019-thym-10.

References

Yang J, Li Q, Ding Y, Cheng-de L . Recurrent Thymoma in the Retroperitoneal Space: A Rare Case Report. Clin Pract. 2015; 5(2):746. PMC: 4500877. DOI: 10.4081/cp.2015.746. View

Schillinger F, Milcent T, Wolf C, Gulino R, Montagnac R . Nephrotic syndrome as the presenting feature of malignant thymoma. Nephrol Dial Transplant. 1998; 12(12):2732-4. DOI: 10.1093/ndt/12.12.2732. View

Takahama Y . Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol. 2006; 6(2):127-35. DOI: 10.1038/nri1781. View

Sandri A, Cusumano G, Lococo F, Alifano M, Granone P, Margaritora S . Long-term results after treatment for recurrent thymoma: a multicenter analysis. J Thorac Oncol. 2014; 9(12):1796-804. DOI: 10.1097/JTO.0000000000000370. View

Jayasena S, Woolfson R, Griffiths M, Neild G . Nephrotic syndrome, malignant thymoma, and myasthenia gravis. Case report and review of the literature. Am J Nephrol. 1995; 15(4):361-3. DOI: 10.1159/000168865. View

Faur D, Martin N, Archuleta J, Torguet P . Quiz page August 2012: a man with nephrotic syndrome and a mediastinal mass. Am J Kidney Dis. 2012; 60(2):A25-7. DOI: 10.1053/j.ajkd.2012.04.021. View

Lasseur C, Combe C, Deminiere C, Pellegrin J, Aparicio M . Thymoma associated with myasthenia gravis and minimal lesion nephrotic syndrome. Am J Kidney Dis. 1999; 33(5):e4. DOI: 10.1016/s0272-6386(99)70444-0. View

Tateyama H, Takahashi E, Saito Y, Fukai I, Fujii Y, Niwa H . Histopathologic changes of thymoma preoperatively treated with corticosteroids. Virchows Arch. 2001; 438(3):238-47. DOI: 10.1007/s004280000333. View

Wright C . Management of thymomas. Crit Rev Oncol Hematol. 2007; 65(2):109-20. DOI: 10.1016/j.critrevonc.2007.04.005. View

10.

Ogawa M, Ueda S, OHTO M, Kono N, Itami J, Kondo Y . Minimal change nephrotic syndrome developed after non-surgical treatment of a thymoma. Clin Nephrol. 1992; 38(3):171-2. View

11.

Valli G, Fogazzi G, Cappellari A, Rivolta E . Glomerulonephritis associated with myasthenia gravis. Am J Kidney Dis. 1998; 31(2):350-5. DOI: 10.1053/ajkd.1998.v31.pm9469510. View

12.

Gharwan H, Tomita Y, Lee M, Thomas A, Berman A, Giaccone G . Alterations of immune cell subsets in relapsed, thymoma-associated minimal change disease: A case report. Oncol Lett. 2015; 10(2):1155-1158. PMC: 4509017. DOI: 10.3892/ol.2015.3325. View

13.

Lien Y, Lai L . Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis. Nat Rev Nephrol. 2010; 7(2):85-95. PMC: 3058941. DOI: 10.1038/nrneph.2010.171. View

14.

Debnath J, Chawla N, Talwar R, Vohra L, George R, Singh H . Pleural and transdiaphragmatic retroperitoneal metastasis developing two and half years after resection of invasive thymoma. Singapore Med J. 2008; 49(3):e64-7. View

15.

White R . The investigation of haematuria. Arch Dis Child. 1989; 64(1):159-65. PMC: 1791808. DOI: 10.1136/adc.64.1.159. View

16.

Bacchetta J, Juillard L, Cochat P, Droz J . Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol. 2008; 70(1):39-58. DOI: 10.1016/j.critrevonc.2008.08.003. View

17.

Lucchi M, Mussi A . Surgical treatment of recurrent thymomas. J Thorac Oncol. 2010; 5(10 Suppl 4):S348-51. DOI: 10.1097/JTO.0b013e3181f20f27. View

18.

Akimoto T, Otani N, Takeshima E, Saito O, Kusano E, Nagata D . Do we have to perform a renal biopsy? Clinical dilemmas in a case with nephrotic syndrome. Clin Med Insights Case Rep. 2014; 7:67-70. PMC: 4125421. DOI: 10.4137/CCRep.S16312. View

19.

Ishida I, Hirakata H, Kanai H, Nakayama M, Katafuchi R, Oochi N . Steroid-resistant nephrotic syndrome associated with malignant thymoma. Clin Nephrol. 1996; 46(5):340-6. View

20.

Karras A, de Montpreville V, Fakhouri F, Grunfeld J, Lesavre P . Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant. 2005; 20(6):1075-82. DOI: 10.1093/ndt/gfh615. View